院士簡歷

Division of Life Sciences

Lieping Chen 陳列平
Election Year 2018
Yale University West Campus
MIC 331, 600 West Campus Drive
West Haven, CT 06516, U.S.A.
Tel: 203-737-1819 / Fax: 203-737-2242
院士email

Current Positions

United Technologies Corporation Chair Professor in Cancer Research, Professor of Immunobiology, Dermatology and Medicine (Medical Oncology), Yale University School of Medicine.

Education

1977-82 M.D., Fujian Medical University, Fuzhou, China
1983-86 Fellow, Cancer Hospital, Peking Union Medical College, Beijing, China
1986-89 Ph.D. in Pathology, Drexel University, Philadelphia, PA, USA

Professional Experience

1981-83 Intern and Resident in Medicine, Fujian Union Hospital, Fuzhou City, China
1989-90 Postdoctoral Fellow, Department of Pathology, University of Washington, Seattle, WA
1990-93 Scientist, Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA
1993-96 Senior Scientist, Bristol-Myers Squibb PRI
1996-97 Principal Scientist, Bristol-Myers Squibb PRI
1997-99 Associate Professor of Immunology, Mayo Clinic, Rochester, MN
1999-04 Professor of Immunology, Mayo Clinic
2004-11 Professor of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD
2004-11 Professor of Dermatology and Research Director, The Johns Hopkins University School of Medicine
2010-11 Jenny Chair in Cancer Research, The Johns Hopkins University School of Medicine
2011-present United Technologies Corporation Chair Professor in Cancer Research, Yale University
2011-present Professor of Immunobiology, Yale University School of Medicine, New Haven, CT
2011-present Professor of Dermatology, Yale University School of Medicine
2011-present Professor of Medicine (Medical Oncology), Yale University School of Medicine
2021- present Visiting Professor, Ludwig Institute for Cancer Research, University of Oxford, Oxford, UK

Specialties

Immunology, Immunotherapy, Cancer

Awards and Honors

1996 Presidential Award, Bristol-Myers Squibb Company
2012 Honorary M.A. Privatim Degree, Yale University
2013 Works cited as “Number 1 Breakthrough of the Year” by Science magazine (for the discovery of anti-PD-1/PD-L1 therapy)
2014 William B. Coley Award for Distinguished Research in Basic and Tumor Immunology, Cancer Research Institute, New York
2016 Innovation Excellence Award, Chinese Association for Science and Technology USA
2016 AAI-Steinman Award for Human Immunology, American Association of Immunologists
2017 Shizhang Bei International Award, the Biophysical Society of China
2017 SCBA Presidential Award, Society of Chinese Bioscientists in America
2017 Warren Alpert Foundation Prize, Warren Alpert Foundation & Harvard Medical School
2018 ACTS Team Science Award, Association for Clinical and Translational Science
2018 Dushu Lake Prize, China Pharmaceutical Innovation and Research Development Association
2018 Luminary Award, World Affairs Council of Connecticut
2018 Giants of Cancer Care Award, OncLive
2018 Kurt Hellman Award, Metastasis Research Society
2018 Elected Academician, Academia Sinica Taiwan
2019 William O. Russell Lectureship & Joanne Vandenberge Hill Award for Anatomy Pathology, The University of Texas MD Anderson Cancer Center
2019 International Cooperation Award, Chinese Society of Clinical Oncology
2019 James Ewing Award, Society of Surgical Oncology
2020 Enrico Mihich Memorial Award and Lectureship, Roswell Park Comprehensive Cancer Center, Buffalo, NY
2020 Richard V. Smalley, MD, Memorial Award and Lectureship, Society for Immunotherapy of Cancer
2021 Elected Fellow, Society for Immunotherapy of Cancer (Inaugural class)
2021 Elected Member, National Academy of Sciences USA
2021 Elected Fellow, American Association for Cancer Research
2022 Distinguished Alumni Award, Fujian Medical University
2022 Elected Member, Connecticut Academy of Science and Engineering
2023 George A. Adrouny Memorial Lectureship, Tulane University School of Medicine, New Orleans, LA